Arya Health (Business/Productivity Software) logo

Arya Health (Business/Productivity Software)

Current Valuation
$73.0M
As of August 18, 2025
Total Funding Raised
$25.4M
Last Round
Early Stage VC

$18.2M

Last Funding
Aug 2025

Funding date

Capital Efficiency
2.87x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Arya Health (Business/Productivity Software) is currently valued at $73.0M as of August 18, 2025. The company has raised a total of $25.4M in funding.

Capital Efficiency

With a capital efficiency ratio of 2.87x, Arya Health (Business/Productivity Software) has achieved a valuation that is 2.87 times the total capital raised. This metric indicates moderate capital efficiency.

Investment Perspective

Arya Health (Business/Productivity Software)'s valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track Arya Health (Business/Productivity Software) Valuation Updates

Get notified when Arya Health (Business/Productivity Software) raises new funding or valuation changes

What is Arya Health (Business/Productivity Software) Worth in 2025?

As of 2025, Arya Health (Business/Productivity Software) is valued at $73.0M, based on the company's Early Stage VC funding round in August 18, 2025. This valuation positions Arya Health (Business/Productivity Software) as one of the leading private companies in the sector.

Arya Health (Business/Productivity Software) Valuation History

Arya Health (Business/Productivity Software)'s funding history demonstrates steady growth and investor confidence.

How Arya Health (Business/Productivity Software) Valuation is Determined

Private company valuations like Arya Health (Business/Productivity Software)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

Arya Health (Business/Productivity Software) Valuation FAQs

Is Arya Health (Business/Productivity Software) profitable?

Arya Health (Business/Productivity Software) has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does Arya Health (Business/Productivity Software)'s valuation compare to competitors?

Arya Health (Business/Productivity Software) is valued at $73.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will Arya Health (Business/Productivity Software) IPO?

Arya Health (Business/Productivity Software) has not announced plans for an initial public offering. Until an IPO, investors can access Arya Health (Business/Productivity Software) shares through secondary market platforms.